JPMA Committee ActivitiesJPMA

Implementation and Management, etc. of Clinical trials under the spread of the novel coronavirus (COVID-19)

 In the serve conditions such as spread of the novel coronavirus (COVID-19), we, the member of JPMA need to carry out clinical trials appropriately, in an effort to prevent the infection spread.
 Clinical Evaluation Expert Committee release a joint statement “Implementation and Management, etc. of Clinical trials under the spread of the novel coronavirus (COVID-19)” in collaborate with Japan Association of Site Management Organizations and Japan CRO Association.



*Click here for the Japanese version
http://www.jpma.or.jp/medicine/shinyaku/tiken/message/covid-19_clinical_trial.html

Page Top

  • Office of Pharmaceutical Industry Research(OPIR)
  • Global Health
  • Stop AMR
  • APAC